Product
Recombinant human monoclonal antibody
1 clinical trial
1 indication
Indication
HIV/AIDSClinical trial
A Randomised Phase II Placebo-controlled Trial of Antiretroviral Therapy (ART) Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs) vs ART Plus Placebo During Primary HIV-1 Infection to Study the Impact on Post-treatment HIV Control.Status: Recruiting, Estimated PCD: 2026-12-10